Evaluation of target organs impairment on patients suffering from high blood pressure - PREVENTA
Study identifier:NIS-CFR-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.
Medical condition
blood pressure
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1200
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jun 2009
Primary Completion Date: -
Study Completion Date: 01 Dec 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 | - |
Contacts
Investigators
Principal Investigator
Alain Castaigne
AstraZeneca
